Lars Nilsson

8.0k total citations
140 papers, 6.2k citations indexed

About

Lars Nilsson is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lars Nilsson has authored 140 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 49 papers in Physiology and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lars Nilsson's work include Alzheimer's disease research and treatments (47 papers), Neuroinflammation and Neurodegeneration Mechanisms (15 papers) and RNA and protein synthesis mechanisms (13 papers). Lars Nilsson is often cited by papers focused on Alzheimer's disease research and treatments (47 papers), Neuroinflammation and Neurodegeneration Mechanisms (15 papers) and RNA and protein synthesis mechanisms (13 papers). Lars Nilsson collaborates with scholars based in Sweden, Norway and United States. Lars Nilsson's co-authors include Lars Lannfelt, C. G. Kurland, Hui Dong, Anna Lord, Erik Vijgenboom, Huntington Potter, Hillevi Englund, Pär Gellerfors, Frida Ekholm Pettersson and Anne Vanet and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Lars Nilsson

136 papers receiving 6.0k citations

Peers

Countries citing papers authored by Lars Nilsson

Since Specialization

Citations

This map shows the geographic impact of Lars Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Nilsson more than expected).

Fields of papers citing papers by Lars Nilsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Nilsson. The network helps show where Lars Nilsson may publish in the future.

Co-authorship network of co-authors of Lars Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Nilsson. A scholar is included among the top collaborators of Lars Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Nilsson. Lars Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease 2023 ·Nature Neuroscience ·(unknown), (unknown), Lothar Gremer, (unknown), Benedikt Frieg, Luisa U. Schäfer, Antje Willuweit, L Donner, Margitta Elvers, Lars Nilsson, Stina Syvänen, Dag Sehlin, Martin Ingelsson, Dieter Willbold, Gunnar F. Schröder	30
2	Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody 2020 ·Scientific Reports ·Kristi Henjum, (unknown), (unknown), Tormod Fladby, Reidun Torp, Lars Nilsson	4
3	Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid 2015 ·Biochimie ·(unknown), Marianne Wettergreen, Lars Nilsson, Tormod Fladby	9
4	Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-β Precursor Protein Transgenic Mice 2014 ·Journal of Biological Chemistry ·(unknown), Hao Cui, Xiao Zhang, Israël Vlodavsky, Lars Nilsson, Jin‐Ping Li	42
5	Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's Disease 2011 ·American Journal Of Pathology ·Anna Lord, Ola Philipson, Therése Klingstedt, Gunilla T. Westermark, Per Hammarström, K. Peter R. Nilsson, Lars Nilsson	33
6	C/EBP delta is down-regulated in response to fibrillar Amyloid-beta both in vivo and in vitro 2010 ·Immunology ·Lincoln M. Tracy, (unknown), (unknown), Lars Nilsson, Kerstin Iverfeldt	1
7	Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice 2009 ·FEBS Journal ·Anna Lord, Hillevi Englund, Linda Söderberg, Stina Tucker, Fredrik Clausen, Lars Hillered, Marcia N. Gordon, Dave Morgan, Lars Lannfelt, Frida Ekholm Pettersson, Lars Nilsson	78
8	A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF) 2007 ·European Heart Journal ·Carina Blomström‐Lundqvist, Bengt Johansson, E Berglin, Lars Nilsson, Steen M. Jensen, S. Thelin, A Jay Holmgren, Nils Edvardsson, Göran Källner, Per Blomström	98
9	APETALA2 like genes from Picea abies show functional similarities to their Arabidopsis homologues 2006 ·Planta ·Lars Nilsson, Annelie Carlsbecker, (unknown), Tiina Vahala	43
10	Amyloid‐β oligomers are inefficiently measured by enzyme‐linked immunosorbent assay 2005 ·Annals of Neurology ·Charlotte Stenh, Hillevi Englund, Anna Lord, Ann‐Sofi Johansson, Cláudia G. Almeida, Pär Gellerfors, Paul Greengard, Gunnar K. Gouras, Lars Lannfelt, Lars Nilsson	88
11	Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences 1999 ·Journal of Biological Chemistry ·Jack T. Rogers, Lorene M. Leiter, James T. McPhee, Catherine M. Cahill, Shanshan Zhan, Huntington Potter, Lars Nilsson	240
12	Effects of nucleus basalis lesion on muscarinic receptor subtypes 1993 ·Experimental Brain Research ·Nenad Bogdanović, Atiqul Islam, Lars Nilsson, (unknown), Bengt Winblad, Abdu Adem	14
13	Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo 1991 ·Clinical & Experimental Allergy ·Christer Peterson, I. Enander, (unknown), Annie S. Anderson, Lars Nilsson, Per Venge	176
14	Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain 1991 ·Journal of the Neurological Sciences ·Lena Bergström, Anita Garlind, Lars Nilsson, Irina Alafuzoff, Christopher J. Fowler, Bengt Winblad, Richard F. Cowburn	48
15	Remoxipride ? a new potential antipsychotic compound 1989 ·Psychopharmacology ·Margaretha Grind, (unknown), Lars Nilsson, (unknown), G�ran Sedvall, (unknown)	21
16	Oocyte Retrieval under the Guidance of a Vaginal Transducer ^a 1988 ·Annals of the New York Academy of Sciences ·Matts Wikland, (unknown), Karin Hammarberg, Lars Nilsson, Lars Hamberger	6
17	Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? 1987 ·Journal of Neural Transmission ·Lars Nilsson, Abdu Adem, John Hardy, Bengt Winblad, Agneta Nordberg	86
18	Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: A model to estimate human turnover of lactoferrin and myeloperoxidase 1987 ·European Journal Of Haematology ·Per Venge, Lars Nilsson, (unknown), T Åberg	20
19	Mutagens in larger fungi 1. 48 species screened for mutagenic activity in the salmonella microsome assay 1982 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Olov Sterner, Rolf Bergman, (unknown), Göran Magnusson, Lars Nilsson, (unknown), (unknown), G. Zetterberg	29
20	Pharmacokinetic Basis for Optimal Methadone Treatment of Pain in Cancer Patients 1982 ·Acta Anaesthesiologica Scandinavica ·L Paalzow, Lars Nilsson, P. Stenberg	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact